Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2010-07-23

European Medicines Agency concludes review of modified-release oral opioids of the WHO level III scale for the management of pain

View source ↗

Summary

The European Medicines Agency concludes its review of modified-release oral opioids used for WHO level III pain management, clarifying safety and appropriate us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications